首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   657篇
  免费   36篇
  国内免费   1篇
林业   36篇
农学   53篇
基础科学   3篇
  156篇
综合类   86篇
农作物   21篇
水产渔业   16篇
畜牧兽医   275篇
园艺   12篇
植物保护   36篇
  2022年   5篇
  2021年   12篇
  2020年   8篇
  2019年   12篇
  2018年   14篇
  2017年   10篇
  2016年   9篇
  2015年   13篇
  2014年   8篇
  2013年   19篇
  2012年   33篇
  2011年   37篇
  2010年   26篇
  2009年   20篇
  2008年   29篇
  2007年   34篇
  2006年   35篇
  2005年   25篇
  2004年   39篇
  2003年   30篇
  2002年   34篇
  2001年   12篇
  2000年   14篇
  1999年   15篇
  1998年   4篇
  1997年   6篇
  1996年   10篇
  1995年   4篇
  1994年   8篇
  1993年   8篇
  1992年   10篇
  1991年   9篇
  1990年   10篇
  1989年   11篇
  1988年   11篇
  1987年   15篇
  1986年   13篇
  1985年   8篇
  1984年   9篇
  1983年   6篇
  1982年   3篇
  1980年   3篇
  1978年   5篇
  1976年   4篇
  1973年   3篇
  1972年   5篇
  1970年   3篇
  1967年   2篇
  1966年   3篇
  1965年   2篇
排序方式: 共有694条查询结果,搜索用时 15 毫秒
691.
The Kepler spacecraft has been monitoring the light from 150,000 stars in its primary quest to detect transiting exoplanets. Here, we report on the detection of an eclipsing stellar hierarchical triple, identified in the Kepler photometry. KOI-126 [A, (B, C)], is composed of a low-mass binary [masses M(B) = 0.2413 ± 0.0030 solar mass (M(⊙)), M(C) = 0.2127 ± 0.0026 M(⊙); radii R(B) = 0.2543 ± 0.0014 solar radius (R(⊙)), R(C) = 0.2318 ± 0.0013 R(⊙); orbital period P(1) = 1.76713 ± 0.00019 days] on an eccentric orbit about a third star (mass M(A) = 1.347 ± 0.032 M(⊙); radius R(A) = 2.0254 ± 0.0098 R(⊙); period of orbit around the low-mass binary P(2) = 33.9214 ± 0.0013 days; eccentricity of that orbit e(2) = 0.3043 ± 0.0024). The low-mass pair probe the poorly sampled fully convective stellar domain offering a crucial benchmark for theoretical stellar models.  相似文献   
692.

Introduction

Aldosterone breakthrough (ABT) is the condition in which angiotensin converting enzyme inhibitors (ACEIs) and/or angiotensin receptor blockers fail to effectively suppress the activity of the renin angiotensin aldosterone system. The objective of this study was to determine if ABT occurs in dogs with naturally occurring myxomatous mitral valve disease receiving an ACEI, using the urine aldosterone to creatinine ratio (UAldo:C) as a measure of renin angiotensin aldosterone system activation.

Animals, Materials and Methods

This study includes 39 dogs with myxomatous mitral valve disease. A UAldo:C cut-off definition (derived from a normal population of healthy, adult, and client-owned dogs) was used to determine the prevalence of ABT in this population. Spearman analysis and univariate logistic regression were used to evaluate the relationship between UAldo:C and ABT (yes/no) and eight variables (age, serum K+ concentration, serum creatinine concentration, ACEI therapy duration and ACEI dosage, furosemide therapy duration and furosemide dosage, and urine sample storage time). Finally, the UAldo:C in dogs receiving spironolactone, as part congestive heart failure (CHF) therapy, was compared to dogs with CHF that were not receiving spironolactone.

Results

The prevalence of ABT was 32% in dogs with CHF and 30% in dogs without CHF. There was no relationship between either the UAldo:C or the likelihood of ABT and the eight variables. Therapy with spironolactone lead to a significant elevation of the UAldo:C.

Discussion

Using the UAldo:C and a relatively stringent definition of ABT, it appears that incomplete RAAS blockade is common in dogs with MMVD receiving an ACEI. The prevalence of ABT in this canine population mirrors that reported in humans. While the mechanism of ABT is likely multifactorial and still poorly understood, the proven existence of ABT in dogs offers the potential to improve the prognosis for MMVD with the addition of a mineralocorticoid receptor blocker to current therapeutic regimens.

Conclusions

Approximately 30% of dogs being treated for heart disease and CHF satisfied the definition of ABT. Identifying patient subpopulations experiencing ABT may help guide future study design and clinical decision-making.  相似文献   
693.
The bulk of the comet 81P/Wild 2 (hereafter Wild 2) samples returned to Earth by the Stardust spacecraft appear to be weakly constructed mixtures of nanometer-scale grains, with occasional much larger (over 1 micrometer) ferromagnesian silicates, Fe-Ni sulfides, Fe-Ni metal, and accessory phases. The very wide range of olivine and low-Ca pyroxene compositions in comet Wild 2 requires a wide range of formation conditions, probably reflecting very different formation locations in the protoplanetary disk. The restricted compositional ranges of Fe-Ni sulfides, the wide range for silicates, and the absence of hydrous phases indicate that comet Wild 2 experienced little or no aqueous alteration. Less abundant Wild 2 materials include a refractory particle, whose presence appears to require radial transport in the early protoplanetary disk.  相似文献   
694.
The effect of genetic substitution of two to four glutenin and gliadin subunits from a Canada Prairie Spring (CPS) cv. Biggar BSR into Alpha 16, another CPS wheat line, was studied for rheological and baking quality. Results from double substitution showed that the presence of a gliadin component from Biggar BSR (BGGL) and low molecular weight glutenin subunit 45 (LMW 45) contributed to improved dough strength characteristics. Presence of BGGL in combination with high molecular weight glutenin subunit 1 (HMW 1) or 17+18 (HMW 17+18) also showed improved dough strength over control Alpha lines. When three or four protein subunits were substituted, even though improved quality performance was observed, it was associated with the negative effect of lowered flour water absorptions in spite of similar protein contents. The study confirms that LMW glutenins, as well as gliadins, play an important role along with HMW glutenins in wheat flour quality. CPS wheat lines with improved dough strength properties can be selected from the double substitution lines with the combination of BGGL/LMW 45 and BGGL/HMW 1.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号